Synnovation Therapeutics is a precision medicine company developing small-molecule therapies targeting validated disease targets.
The company discovers and develops therapeutics for people living with cancer. The company aims to advance its agents into clinical trials using patient-focused precision medicine.
Based on the company’s public LinkedIn information, supplied through RevenueBase.
The company is building a diverse pipeline of novel small-molecule targeted therapies, drawing on expertise in cancer biology and medicinal chemistry.
Source: LinkedIn company description · Retrieved October 13, 2026
Supported appearances on published RevenueBase lists, including available memberships beyond displayed rankings.
Positions describe ordering within each source list. See how lists are built ↗
Embeddable award for your website
Open the published source list.RevenueBase prepared this profile from the company’s public LinkedIn information and RevenueBase company data. These source records were retrieved on October 13, 2026. AI helped summarize these sources, with a separate automated check against the source text completed on November 4, 2026. Directory positions use company-contact counts from separate saved list snapshots dated September 15, 2026, September 16, 2026, September 18, 2026, September 21, 2026, September 30, 2026 and October 7, 2026. How the company lists are built.
Share a correction, your relationship to the company, and supporting sources. Requests are reviewed before changes are published.
Explore more companies by name, headquarters and business focus.